Overproduction of glutamate by Corynebacterium glutamicum is induced by biotin limitation or by the supplementation of specific detergents, sublethal amounts of penicillin, or cerulenin. But, it remains unclear why these different treatments, which have different sites of primary action, produce similar effects.
1)
Glutamate is prominent among the fermentatively produced amino acids; each year 1.5 million tons of glutamate is produced in the form of its monosodium salt throughout the world.
Glutamate overproduction in C. glutamicum is induced by biotin limitation 2) or by the supplementation of specific detergents such as polyoxyethylene sorbitan monopalmitate (Tween 40), 3) a sublethal concentration of penicillin, 4) or cerulenin to the media. 5) Recent reports have revealed that the activity of the 2-oxoglutarate dehydrogenase complex (ODHC) is greatly reduced during glutamate overproduction; 6, 7) this leads to an increase in the carbon flow toward glutamate synthesis from oxoglutarate at the branch point. 8) Recently, dtsR1 was cloned as a multicopy suppressor gene that overcame the hypersensitivity of a mutant strain to Tween 40. 9) The amino acid sequence of DtsR1 showed homology to that of a subunit of acyl-coenzyme A (CoA) carboxylases of various origins, and the disruption of dtsR1 resulted in fatty acid auxotrophy. Hence DtsR1 is assumed to represent a subunit of acetylCoA carboxylase, 10) which catalyzes the first reaction in fatty acid biosynthesis. 11, 12) Based on studies on dtsR1, a decrease in the cellular concentration of DtsR1 caused by biotin limitation and Tween 40 supplementation is assumed to trigger the reduction in ODHC activity that leads to glutamate overproduction. 13) In the case of penicillin treatment, however, no decrease in the cellular concentration of DtsR1 has been observed. 13) Different treatments that have different sites of primary action, namely, inhibition of fatty acid biosynthesis and inhibition of peptide crosslinking for peptidoglycan formation, exhibit similar effects, but the reason for this is unknown. ineae, which includes well-known bacteria such as Mycobacterium tuberculosis, Mycobacterium leprae, and Corynebacterium diphtheriae. These bacteria have characteristic constituents-mycolic acids-on their outer cell surface. 15) Mycolic acids are synthesized from two fatty acid chains by a condensation reaction catalyzed by polyketide synthase, 16, 17) and together with other cellwall components they form the outer cell layer.
18) The mycolic acid layer, which is attached to the cell wall, has been shown to play a crucial role in the resistance of these microorganisms to various antibiotics. [19] [20] [21] [22] Based on its structural characteristics, it is possible that the mycolic acid layer is involved in glutamate overproduction. But no studies are available in this regard, while a few studies have reported the possibility of a relationship between changes in the cell surface structure and glutamate overproduction. 14, 15, 22) The results of our study suggest that the different treatments, which have different sites of primary action, produce the same effect, which results in defects in the mycolic acid layer. This might be one of the key factors in glutamate overproduction by C. glutamicum.
Materials and Methods
Chemicals and enzymes. Tween 40, Tween 80 (polyoxyethylene sorbitan monooleate), and cerulenin were purchased from Wako Pure Chemical Industries (Osaka, Japan). Penicillin G was purchased from Merck (Darmstadt, Germany). N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline, 4-aminoantipyrine, peroxidase, and glutamic acid oxidase were purchased from Yamasa (Chiba, Japan).
Strains and culture conditions. Cells of a wild-type C. glutamicum (ATCC13869), were grown on a CM2B 23) plate for 24 h at 31.5 C. The cells were harvested from one-eighth of the plate and inoculated in a flask containing 20 ml glutamate production medium comprising glucose, 60 g/l; (NH 4 ) 2 SO 4 , 30 g/l; KH 2 PO 4 , 1 g/l; MgSO 4 -7H 2 O, 0.4 g/l; FeSO 4 -7H 2 O, 0.01 g/l; thiamine, 0.2 mg/l; d-biotin, 60 mg/l; 0.48 g nitrogen of soybean protein hydrolysate/l; and CaCO 3 , 50 g/l. After 24 h of cultivation at 31. 5 C on a reciprocal shaker, 2 ml culture was inoculated into 20 ml fresh glutamate production medium. To create biotin-limited conditions, 3.0 mg/l of d-biotin was added to the medium. After 3 h of cultivation at 31. 5 C on a reciprocal shaker, Tween 40, penicillin G, or cerulenin was added to the medium to yield final concentrations of 1.5 g/l, 2,200 U/l, and 6.6 g/l respectively. Subsequently, after 18 h of cultivation at 31.5 C, the cell mass was determined by measuring absorbance at 600 nm, and the cells were harvested by centrifugation. The amount of glutamate in the medium and the mycolic acid content were analyzed.
Determination of glutamate. The amount of glutamate was enzymatically determined using glutamate oxidase, 24) which produces hydrogen peroxide, 2-oxoglutaric acid, and ammonia from glutamate. The resulting hydrogen peroxide was used by peroxidase to produce a blue pigment from N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline and 4-aminoantipyrine. The amount of blue pigment was determined by measuring absorbance at 600 nm.
Determination of mycolic acid content and structure. Determination of mycolic acid content and structure was performed essentially as previously described.
25) The cells were harvested and freeze-dried. One gram of freeze-dried cells was suspended in 2 ml 10% methanolic KOH and incubated at 100 C for 2 h. After cooling, the reaction mixture was acidified with 6 N HCl. The resulting free mycolic acids and fatty acids were extracted with hexane, and subsequently the solvent was evaporated. The residues were dissolved in 2 ml of a mixture of benzene-methanol-sulfuric acid (10:20:1) and incubated at 100 C for 2 h. Methylesterified mycolic acids and fatty acids were extracted twice with n-hexane and the solutions were concentrated. The concentrated solutions were spotted onto a silica gel plate and developed using n-hexane/diethyl ether as the eluent (4:1). Methyl-esterified mycolic acids and fatty acids were detected by iodine vapors. Mycolic acids were extracted from the silica gel using chloroform, followed by evaporation of the solvent. Following this, 100 ml of N,O-bis-(trimethylsilyl)-trifluoroacetamide (BSTFA) and 50 ml of pyridine were added to the residue, and the mixture was incubated at 70 C for 20 min. After cooling, 2 ml benzene was added and the solvent was evaporated. Trimethylsilylated mycolic acid methyl esters were analyzed by gas chromatography (GC) on a Shimadzu GC-7A (Kyoto, Japan) system using an OV-1 (0.5 m) column. The temperature of the injector was 350 C, the flow rate of the carrier gas (helium) was 50 ml/min, and the column temperature was programmed from 220 C to 270 C at 2 C/min. Since mycolic acid standards were not available, the relative values of the areas to those of the control were used and normalization was carried out with the amount of protein in each sample.
GC-MS analysis was performed on an HP5890II (Hewlett-Packard, Palo Alto, CA) system connected to an HP5971 (Hewlett-Packard) using a J&W DB-5ms (30 m Â 0:25 mmID) column (Agilent Technologies, Palo Alto, CA). The temperature of the injector was 320 C and the column temperature was 300 C. The ionization mode was electron ionization (EI) at 70 eV.
Results
Mycolic acids of C. glutamicum As described above, little information is available regarding the molecular mechanism of glutamate overproduction by C. glutamicum. The reason different treatments have a similar effect although their sites of primary action are different remains unclear.
Based on the structure and features of the mycolic acid layer, the possibility of its involvement in glutamate overproduction was anticipated. It was assumed that the mycolic acid content of glutamate-overproducing C. glutamicum would be lower than that of nonproducing C. glutamicum because acetyl-CoA carboxylase, which is involved in fatty acid synthesis, would be limited by biotin limitation or by Tween 40 supplementation, and fatty acid synthase would be inhibited by cerulenin. A similar assumption can be made in the case of penicillin supplementation, because the mycolic acid layer is attached to the arabinogalactan layer, which is covalently bound to the peptidoglycan layer.
Prior to investigating the changes in mycolic acid composition and the content of glutamate-overproducing C. glutamicum, mycolic acid of C. glutamicum cultivated under normal conditions was analyzed by GC and GC-MS.
As shown in Fig. 1 , five major peaks, designated P 1 , P 2 , P 3 , P 4 , and P 5 , were detected. The most abundant mycolic acid was P 4 (retention time, 14.15 min), which accounted for 71:8% AE 1:0% (mean value AE standard error of four independent experiments) of total mycolic acid. This was followed by P 3 (retention time, 9.62 min), which accounted for 13:5% AE 0:5% of total mycolic acid, and P 5 (retention time, 17.53 min), which accounted for 8:8% AE 0:2% of total mycolic acid.
The structure of mycolic acid in this organism was analyzed by GC-MS. The scheme of fragmentation of trimethylsilylated mycolic acid methyl esters has been reported, as shown in Fig. 2 . [25] [26] [27] As a consequence of high frequency fragmentation, the molecular ion peak is barely detected; 25, 27) rather, the M-15 peak formed by the elimination of a methyl group is often detected. 25, 27) The structures of R 1 and R 2 can be deduced from the structures of fragment A, fragment B, and B-29 (See Fig. 2 ).
As shown in Fig. 3 , the mass spectra of all the major peaks P 1 -P 5 in Fig. 1 possessed a peak at m/e 73, a derivative of trimethylsilylether.
25) The mass spectrum indicated that the mycolic acid of P 1 was C 26 , because the mass ion peak at m/e 483 appeared to be M-15 (Fig. 3A) . The intense peak at m/e 229, which was most probably formed by cleavage of the C-C bond between the and position and resulted in the formation of fragment A in Fig. 2 , indicates that this mycolic acid was formed by the condensation chiefly of C 10 (R 1 ) and C 16 (R 2 ) (Fig. 3A) . This interpretation was confirmed by the peak at m/e 342, which corresponded to B-29, while the peak corresponding to fragment B (m/e 371) was weak. The peaks at m/e 313, 287, and 258 also indicates condensation of C 10 and C 16 in another manner (R 1 ¼ C 16 , R 2 ¼ C 10 ), while their intensities were very weak. Correspondingly, the mass spectra shown in Fig. 3 indicate that the mycolic acids of P 2 , P 3 , P 4 , and P 5 were C 28 , C 30 , C 32 , and C 34 respectively. These were formed chiefly by C 12 and C 16 (Fig. 3B) , C 14 and C 16 (Fig. 3C) , C 16 and C 16 (Fig. 3D) , and C 16 and C 18 (Fig. 3E) respectively.
Changes in the composition and content of mycolic acids in glutamate-overproducing C. glutamicum
Mycolic acids in glutamate-overproducing C. glutamicum were analyzed by GC and GC-MS. The results obtained from C. glutamicum cultivation for glutamate overproduction are summarized in Table 1 . The amounts of glutamate were 121 mM, 122 mM, 101 mM, and 113 mM under the biotin limitation condition and under conditions in which Tween 40, penicillin G, and cerulenin respectively were added.
The results of GC analysis are shown in Fig. 4 , and the relative amounts of each mycolic acid to the total mycolic acid are shown in Table 2 . The content of short mycolic acids increased under the conditions of biotin limitation and cerulenin supplementation, and extremely short mycolic acids appeared under that of cerulenin Mycolic acids of C. glutamicum cultivated under normal condition (biotin-rich media) were extracted and modified, as described in ''Materials and Methods''. Five major peaks (P 1 -P 5 ) have been designated in order of retention time.
Fig. 2. Scheme of Fragmentation of Trimethylsilylated Mycolic Acid
Methyl Esters in Mass Spectrometry. The cleavage sites of trimethylsilylated mycolic acid methyl esters that occurred with high frequency due to electron impact are illustrated.
Fig. 3. Mass Spectra of Trimethylsilylated Mycolic Acid Methyl Esters of C. glutamicum.
A, Mass spectrum of the P 1 peak in Fig. 1 . B, Mass spectrum of the P 2 peak in Fig. 1 . C, Mass spectrum of the P 3 peak in Fig. 1 . D, Mass spectrum of the P 4 peak in Fig. 1 . E, Mass spectrum of the P 5 peak in Fig. 1 . Conditions are described in ''Materials and Methods''. Structures of mycolic acid determined by mass spectroscopy are also shown with their molecular weights, as well as fragments A and B shown in Fig. 2 . Overproduction. Mycolic acids of glutamate-overproducing C. glutamicum were extracted and modified as described in ''Materials and Methods''. supplementation ( Fig. 4 and Table 2 ). The mass spectra of these unusual peaks confirmed their lower molecular masses and confirmed that their structure is composed of short fatty acids. The mycolic acid of P b was C 22 formed chiefly by C 10 and C 12 (Fig. 5A) , and that of P c was C 24 formed chiefly by C 8 and C 16 (Fig. 5B) . The mycolic acid of P a was not analyzed on MS, but it must be C 20 , based on its retention time on GC and the results described above.
As shown in Fig. 6 , the total mycolic acid content of glutamate-overproducing C. glutamicum was reduced under all conditions that induced glutamate overproduction, viz., biotin limitation and the supplementation of Tween 40, penicillin, and cerulenin. In the presence of Tween 40, penicillin, and cerulenin, the mycolic acid content was greatly reduced, to approximately 60% of the control value, while under the biotin-limited condition, the extent of reduction was less than that in the other conditions. Although the reduction in total mycolic acid content under the biotin-limited condition was smaller, defects in the mycolic acid layer must occur due to the increase in short mycolic acids.
Discussion
Our results indicate that the major mycolic acids of the strain cultivated under normal condition were C 30 , C 32 , and C 34 , and that the proportion of the most abundant mycolic acid (C 32 ) to total mycolic acid was approximately 70%. This is not completely consistent with previous study, which found that the carbon number of C. glutamicum mycolic acids varied between 32 and 36 and, that the most abundant mycolic acid was C 34 . 18) This inconsistency might be due to the difference in the strain used and/or the difference in the culture conditions.
GC-MS analysis indicated that the most abundant C 32 mycolic acid was composed of two C 16 fatty acids, which reflects the fact that one of the most abundant fatty acids of C. glutamicum is palmitate (C 16 ). 5, 28) Interestingly, another abundant fatty acid, viz., oleate (C 18:1 ), was scarcely present in mycolic acid, which might account for the substrate specificity of the enzyme(s) involved in mycolic acid synthesis in microorganisms grown under the experimental conditions. This observation suggests the need to understand mycolic acid biosynthesis in detail.
The total mycolic acid content of glutamate-overproducing C. glutamicum was reduced under all conditions as compared with that under the normal condition. The reduction in total mycolic acid content under biotin limitation, Tween 40 supplementation, or cerulenin supplementation might have been due to the lack of fatty acid biosynthesis; fatty acids are the building blocks of mycolic acid. On the other hand, the reduction under the condition of penicillin supplementation might have been due to the lack of a scaffold to attach mycolic acid to the cell wall, i.e., the peptidoglycan layer, which is covalently bound to the arabinogalactan layer. Furthermore, the content of short mycolic acids increased under the conditions of biotin limitation and cerulenin supplementation, with extremely short mycolic acids appearing under the latter condition. These results suggest that defects in the mycolic acid layer are caused under all conditions that induce glutamate overproduction, although the extent of reduction in mycolic acid content under the biotinlimited condition was less than that under the other conditions. Considering the structural characteristics of the mycolic acid layer, which plays a crucial role in the resistance of Mycobacterium to various antibiotics, [19] [20] [21] Mycolic acids of glutamate-overproducing C. glutamicum were extracted and modified, as described in ''Materials and Methods''. Since mycolic acid standards were not available, relative values of the areas to those of the control were used, and normalization was carried out with the amount of protein in each sample. The mean value with standard error from four experiments with biotin limitation and Tween 40 supplementation, from three experiments with penicillin supplementation, and from two experiments with cerulenin supplementation, are shown. the mycolic acid layer might function as a barrier to glutamate excretion, and defects in the mycolic acid layer are perhaps one of the key factors in glutamate overproduction. Our results suggest that the different treatments, which have different sites of primary action, produce the same effect that causes the defects in the mycolic acid layer.
The increase in short mycolic acids under the conditions of biotin limitation and cerulenin supplementation perhaps result from the arrest of biosynthesis of fatty acids caused by these treatments. Of the conditions that induce glutamate overproduction, biotin limitation, Tween 40 supplementation, and cerulenin supplementation were considered to cause the defect in fatty acid biosynthesis. But, penicillin supplementation was not considered to cause the defect in fatty acid biosynthesis, since the total fatty acid content of the glutamate-overproducing C. glutamicum, normalized with dry cell weight, remained almost intact. 29) Thus the reason these different treatments, which have different sites of primary action, produce the same effect is unclear thus far. Our present results indicate that these treatment produce the same effect that causes the defects in the mycolic acid layer. Most recently, Radmacher et al. reported that glutamate overproduction by C. glutamicum was induced by the supplementation of ethambutol, an inhibitor of cell wall biosynthesis, and that the content of mycolic acid was reduced in C. glutamicum treated with ethambutol. 30) Their observations are consistent with and confirmed our result that the defects in the mycolic acid layer occur in glutamate-overproducing C. glutamicum.
Although the mechanism that underlies the changing metabolic flux towards glutamate overproduction under these treatments remains unclear, the results presented here reveal a novel common feature of glutamateoverproducing C. glutamicum. This feature is probably important for detailed understanding of the molecular mechanisms of glutamate overproduction by C. glutamicum.
